刺激性肠综合征的诊断和管理的最新情况
Tsung-Hsing Hung1,2, Chih-Ying Wang3, Hsing-Feng Lee1,2
1Division of Gastroenterology, Department of Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.
Tzu chi medical journal
|November 30, 2023
概括
刺激性肠综合征 (IBS) 是一种复杂的功能性胃肠疾病. 有效的管理需要个性化的治疗计划,结合基于患者的非药物和药物疗法.
科学领域:
- 胃肠病学 胃肠病学
- 功能性胃肠道疾病 功能性胃肠道疾病
背景情况:
- 刺激性肠综合征 (IBS) 是一种功能性胃肠疾病,缺乏结构或生化异常.
- 诊断依赖于罗马四号标准,建议采用多维临床概况 (MDCP) 方法.
- IBS的病理生理学是多因素的,涉及运动性,遗传学,免疫反应,内脏过敏,大脑肠道失调和微生物群变化.
研究的目的:
- 审查当前对刺激性肠综合征 (IBS) 病理生理学的理解.
- 概述IBS的各种非药物和药物管理策略.
- 强调个人化,多学科治疗方法对IBS的重要性.
主要方法:
- 关于IBS诊断,病理生理学和治疗选择的文献评论.
- 综合关于非药物疗法 (饮食,体育活动,CBT) 的信息.
- 对包括益生菌,抗抑郁药,抗药和新药在内的药理疗法的分析.
主要成果:
- IBS的诊断是基于罗马四号标准和MDCP.
- 关键的病理生理因素包括肠道运动性,遗传学,免疫功能,内脏敏感性,脑肠轴和微生物群.
- 管理包括体力活动,饮食变化 (低FODMAP),CBT,益生菌,抗药和抗抑郁药.
结论:
- 综合非药物和药物治疗的多学科战略对于IBS管理至关重要.
- 临床医生必须考虑个体的病理生理学,以选择适当的治疗方案.
- 个性化治疗计划对于有效的IBS管理至关重要.
相关概念视频
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
212
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
212
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
165
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
165
01:17Drugs for Treatment of Diarrhea-Predominant IBS
182
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
182
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
01:17Irritable Bowel Syndrome I: Introduction
280
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
01:21Drugs for Treatment of Constipation-Predominant IBS
179
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
179